Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

2024187 citationsJournal Article

Authors

Colleen F. Kelley · Grady Health System

Maribel Acevedo-Quiñones · Department of Natural and Environmental Resources

Allison L. Agwu · Johns Hopkins University

Anchalee Avihingsanon · HIV Netherlands Australia Thailand Research Collaboration

Paul Benson

Jill Blumenthal · University of California San Diego

Cynthia Brinson

Carlos Brites

Abstract

The HIV incidence with twice-yearly lenacapavir was significantly lower than the background incidence and the incidence with F/TDF. (Funded by Gilead Sciences; PURPOSE 2 ClinicalTrials.gov number, NCT04925752.).

Topics & Keywords

HIV/AIDS Research and Interventions Syphilis Diagnosis and Treatment HIV Research and Treatment

UN Sustainable Development Goals

Gender equality

Publication Details

Published in: New England Journal of Medicine

Volume 392, Issue 13, pp. 1261-1276

DOI: 10.1056/nejmoa2411858

Field-Weighted Citation Impact: 72.01